Back To: Home

Our 2020 Media Kit is now available
Your gateway to the latest oncology news, trends and resources
Inside this issue:
October 2020
Wave Life Sciences releases preclinical data for ADAR editing and C9orf72 program...
by Kelsey Kaustinen
October 2020
Scripps team identifies molecule that can bind to RNA to increase VEGF-A production...
by Kristen Smith
October 2020
DDN spoke with Dr. Michael Snape, chief scientific officer of AMO Pharma, to discuss drugs that target the ERK signaling cascade, and how these drugs might be able to treat a range of developmental disorders...
by Mel J. Yeates
October 2020
Researchers are increasingly targeting autoimmunity rather than hyperglycemia as they search for better ways to treat type 1 diabetes...
by Randall C Willis
Patent Docs:
Interplay between obviousness and satisfaction invalidates claims in Biogen Tecfidera patent
Kevin Noonan explores a patent ruling that shows how the same evidence that supports non-obviousness can run up against the problem of potentially restricting the scope of what has been described, click here.

Editor's Focus:
October 2020
RNA-seq offers a comprehensive method for studying differential gene expression and changing levels of noncoding RNAs at both the single-cell and bulk sequencing levels, thus offering a powerful arsenal of investigative tools for understanding the molecular basis of disease and for the discovery and testing of new treatment options.. [ more ]
by Dr. Rachel West of Roche

October 2020
Science is knowing you never have a complete answer and challenging any answer that arises. To the general public, however, this uncertainty rankles at a minimum and terrifies in its extreme. .. [ more ]
by Randall C Willis

October 2020
DDN is evolving in all its forms, from print to online, and we look forward to unveiling it all soon.. [ more ]
by Jeffrey Bouley

1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by Offenberger & White.